. Dyfarnwyd yr anrhydedd o 'cyfraniad rhagorol i werth allbwn diwydiannol gros blynyddol 100 biliwn ' yng Nghynhadledd Datblygu Economaidd 2022 Parth Datblygu Dosbarth Linping District District District District Dosbarth, sydd newydd ddod i ben Derbyniodd Mr. Ren Yunhua, rheolwr cyffredinol Joytech, y wobr ar ran y cwmni.
Yn ystod y flwyddyn ddiwethaf, mae Joytech wedi goresgyn llawer o ffactorau anffafriol ac wedi arwain at ddatblygiad cynhwysfawr, ac wedi cyflawni'r nod o ymosod ac amddiffyn. Yn y dyfodol, byddwn hefyd yn parhau i dyfu'n fwy ac yn gryfach yn y parth datblygu. Byddwn yn parhau i gyflwyno, treulio ac amsugno technolegau dyfeisiau meddygol cartref uwch ac yn parhau i hyrwyddo datblygiad pen uchel dyfeisiau meddygol.
On the other hand, we will take the existing R&D center as a platform, cooperate with the development zone and excellent enterprises at home and abroad, integrate resources, collaborate and innovate, complete the docking with 'Made in China 2025', help the development zone build strategic and technology-intensive industrial clusters, and strive to realize 'global medical products' as soon as possible. Gweledigaeth y Cwmni o 'Arweinydd Cynhyrchion Meddygol Byd -eang '!
In addition to this honor, on January 6, Joytech Healthcare CO.,LTD was also recognized as one of the 'Specialized, Refined, Specialized and Novel' Small and Medium Enterprises in Zhejiang Province for the year 2021, which is at the leading level of the same industry in China in terms of technology, market, quality and efficiency, and has advanced and exemplary.
